A radioimmunoprecipitation-polyacrylamide gel electrophoresis technique was applied to sera from canine distemper virus-infected dogs. Sera from fatally infected dogs precipitated only the nucleoprotein, the matrix protein, and trace amounts of fusion glycoprotein. Sera from normal convalescent dogs precipitated all five major polypeptides. In contrast, sera from persistently infected dogs were characterized by a modest overall response compared with sera from convalescent dogs and by no or little response to the matrix and phosphorylated proteins until 5 to 7 weeks after infection.
Canine distemper virus (CDV), a morbillivirus closely related to measles virus, is a serious pantropic viral disease of dogs. The virus is ordinarily spread from infected to uninfected dogs by aerosols. The early events of pathogenesis are well documented (1, 2, 6, 12, 24) . The magnitude of the humoral immune response to CDV (1, 2, 16) correlates with the eventual outcome of the infection. A delayed or diminished complement-fixing antibody response to virion envelope antigens occurs in animals with persistent neurological disease (16) . More precise delineation of the immune response to individual virion polypeptides in these canine sera can be made by radioimmunoprecipitation-polyacrylamide gel electrophoresis (RIP-PAGE).
For this study, serum samples were obtained (15, 16, 18, 19) before inoculation and at each post-inoculation week (PIW) from 16 R252-CDV-infected gnotobiotic dogs (14) . The Dogs that develop acute fatal encephalomyelitis (group 1) after infection have little or no virus-neutralizing antibody in their sera (16) . Analysis of the serum samples by RIP-PAGE revealed that they were devoid of antibody to CDV hemagglutinin-equivalent (H) and phosphorylated (P) proteins and contained only limited amounts of antibody to CDV nucleocapsid (NP) protein, fusion (F) glycoprotein, and matrix (M) protein from PIW 1 until death (Fig. 2) . Modest responses to the CDV NP and F proteins were first noted at PIW 1 in the persistently infected dogs of group 2 (Fig. 3) . By PIW 4, antibody to these two proteins reached peak levels. Antibody to the three remaining virion polypeptides, H, P, and M, was first detected at PIW 3. Modest levels of anti-H protein persisted throughout the observation period, whereas increases beyond trace levels for the P and M proteins were noted from PIWs 5 through 7 onward. In contrast to the results for groups 1 and 2, sera collected from the convalescent group 3 dogs reacted promptly and strongly (PIW 2 onward) with all of the polypeptides (Fig.   4 ). persistently infected group 2 dogs. Study of these serum samples by the complement-fixing antibody test suggested that the relative lack of antibody to ether-sensitive envelope antigen is a characteristic serological marker of persistence (16) . The paucity of response to the H and F proteins by this group early in the course of the disease compared with that of group 3 dogs supported this hypothesis. More intriguing than this, however, was the delay in the appearance of significant quantities of antibody to the M protein (and to a lesser extent the P protein) until PIW 5 to 7 and after at least 4 weeks of CDV residence and replication within the brain (24). In this respect the pattern of antibody responses during this time resembled the pattern of response in subacute sclerosing panencephalitis (SSPE), a measles virus-associated chronic fatal neurological disease of humans (20, 21) . SSPE patients apparently lack antibody to the measles virus M protein in spite of showing exaggerated responses to other measles virus virion proteins (7, 10) . Although several explanations for this have been offered, it seems likely that the measles virus variants of SSPE lack the ability to synthesize the M protein (7, 8, 17) . Dogs destined to develop persistent infection apparently go through a phase of infection serologically resembling SSPE. This infection differs from SSPE in the ultimate development by the dogs of antibodies to all of the virion proteins, including M. This distinction between SSPE and persistent CDV infection has been made by others (9) . Thus, our data suggest that either a transient lack of production of the M protein by the virus in vivo or, more likely, a lack of prompt development of antibody to the M protein is characteristic of persistent infection and may be a critical event in the in vivo evolution of persistent paramyxovirus infection in the brain. If this hypothesis is true, then further studies on the role of this protein in the establishment or maintenance of persistent infection by CDV seem to be warranted. We acknowledge the helpful advice of W. W. Hall and A. Movely, The Rockefeller University, New York, N.Y., during the development of the RIP-PAGE assay and the excellent technical assistance of Geralyn Duska.
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